{"count": 2, "results": [{"_id": "34850313", "pmid": 34850313, "title": "Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-alpha production.", "journal": "Inflammopharmacology", "authors": ["Augusto PSA", "Matsui TC", "Braga AV", "Rodrigues FF", "Morais MI", "Dutra MMGB", "Batista CRA", "Melo ISF", "Costa SOAM", "Bertollo CM", "Coelho MM", "Machado RR"], "date": "2022-02-01T00:00:00Z", "doi": "10.1007/s10787-021-00899-4", "meta_date_publication": "2022 Feb", "meta_volume": "30", "meta_issue": "1", "meta_pages": "233-241", "score": 50245.766, "text_hl": "Altogether, these results stimulate the conduction of studies aiming to evaluate whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may be repositioned in the treatment of @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Somatoform_Disorders</m> @DISEASE_MESH:D013001 @@@painful and inflammatory disorders@@@.", "citations": {"NLM": "Augusto PSA, Matsui TC, Braga AV, Rodrigues FF, Morais MI, Dutra MMGB, Batista CRA, Melo ISF, Costa SOAM, Bertollo CM, Coelho MM, Machado RR. Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-alpha production. Inflammopharmacology. 2022 Feb;30(1):233-241. PMID: 34850313", "BibTeX": "@article{34850313, title={Metformin effect in models of inflammation is associated with activation of ATP-dependent potassium channels and inhibition of tumor necrosis factor-alpha production.}, author={Augusto PSA and Matsui TC and Braga AV and Rodrigues FF and Morais MI and Dutra MMGB and Batista CRA and Melo ISF and Costa SOAM and Bertollo CM and Coelho MM and Machado RR}, journal={Inflammopharmacology}, volume={30}, number={1}, pages={233-241}}"}}, {"_id": "31238066", "pmid": 31238066, "title": "Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanisms.", "journal": "Eur J Pharmacol", "authors": ["Augusto PSA", "Braga AV", "Rodrigues FF", "Morais MI", "Dutra MMGB", "Batista CRA", "Melo ISF", "Costa SOAM", "Goulart FA", "Coelho MM", "Machado RR"], "date": "2019-09-05T00:00:00Z", "doi": "10.1016/j.ejphar.2019.172497", "meta_date_publication": "2019 Sep 5", "meta_volume": "858", "meta_issue": "", "meta_pages": "172497", "score": 50047.438, "text_hl": "Altogether, the results indicate that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ should be further investigated aiming its repositioning in the treatment of @SPECIES_9606 @@@patients@@@ with different @<m>DISEASE_Somatoform_Disorders</m> @DISEASE_MESH:D013001 @@@painful conditions@@@.", "citations": {"NLM": "Augusto PSA, Braga AV, Rodrigues FF, Morais MI, Dutra MMGB, Batista CRA, Melo ISF, Costa SOAM, Goulart FA, Coelho MM, Machado RR. Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanisms. Eur J Pharmacol. 2019 Sep 5;858():172497. PMID: 31238066", "BibTeX": "@article{31238066, title={Metformin antinociceptive effect in models of nociceptive and neuropathic pain is partially mediated by activation of opioidergic mechanisms.}, author={Augusto PSA and Braga AV and Rodrigues FF and Morais MI and Dutra MMGB and Batista CRA and Melo ISF and Costa SOAM and Goulart FA and Coelho MM and Machado RR}, journal={Eur J Pharmacol}, volume={858}, pages={172497}}"}}]}